Delivery Order SPE2DR25D2002-SPE2DR26FBSQ3
- Not listed
- The Defense Logistics Agency awarded a $146,369.15 delivery order to AmerisourceBergen Drug Corp for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML meningococcal vaccine, with an ultimate completion date of November 26, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded competitively on November 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.66 to AmerisourceBergen Drug Corp for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The award was made on May 16, 2025, with an ultimate completion date of May 19, 2025, utilizing firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $175,856.28 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. The contract is scheduled for completion by June 23, 2025, and performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under an existing indefinite delivery contract vehicle, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL, a meningococcal conjugate vaccine, with a ceiling value of $1,613.15. This firm fixed-price delivery order, which is set to be completed by August 8, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,966.52 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price contract, with an ultimate completion date of July 24, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's existing pharmaceutical supply vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $165,523.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. The contract, which was not set-aside and competitively awarded, is scheduled for completion by September 5, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,195.49 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The order is scheduled for completion by June 2, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,231.88 on November 3, 2025, under a firm fixed-price contract. The order covers Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a conjugate meningococcal vaccine, with delivery required by November 4, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the company's capability to...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,087.40 delivery order on November 5, 2025, for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. The award, which has no set-aside designation, represents a firm fixed-price delivery order with an ultimate completion date of November 6, 2025, and will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is a child award issued under a larger contract vehicle....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,193.10 delivery order on November 25, 2025, for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. This firm fixed price, non-set-aside contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 26, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DR25D2002Indefinite Delivery Contract
- SPE2DR25D2002-SPE2DR26FBSQ3Delivery Order
The Defense Logistics Agency awarded a $1,626.27 delivery order to AmerisourceBergen Drug Corp for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine, with performance in Conshohocken, Pennsylvania and a completion date of December 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply relationships with the Defense Logistics Agency. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a leading pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies critical medical commodities including vaccines, specialty medications, and generic drugs to support military healthcare programs and other federal health systems worldwide. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse pharmaceutical procurement requirements for the Department of Defense and related federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/14/25 |